Document is current
Any future updates will be listed below
-
Authors
Zheng, Yanan https://orcid.org/0000-0003-3076-0003
Wire, Mary
Omange, Robert Were
deVries, Christiaan R.
Zhang, Liao
Chen, Buyun
Huang, Susie S. Y.
Cruz, Kimberly
Hassman, Howard
Osiyemi, Olayemi
Rondon, Juan Carlos
Lim, Daina
West, Steve
Wen, Anita
Wallin, Jeffrey J.
SenGupta, Devi
Cai, Yanhui
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05458102 at ClinicalTrials.govDocuments that mention this clinical trial
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV
https://doi.org/10.1007/s40121-025-01227-x
-
Funding
Funding for this research was provided by:
Gilead Sciences
- License Information
-
More Information
Article History
Received: 13 June 2025
Accepted: 26 August 2025
First Online: 15 September 2025
Declarations
:
: Yanan Zheng, Mary Wire, Liao Zhang, Daina Lim, Steve West, Devi SenGupta, and Anita Wen are employees of Gilead Sciences, Inc., and may own shares or stocks in Gilead Sciences, Inc. Robert Were Omange, Christiaan R. deVries, Buyun Chen, Susie S.Y. Huang, Jeffrey J. Wallin, and Yanhui Cai are former employees of Gilead Sciences, Inc. and may own shares or stocks in Gilead Sciences, Inc. Olayemi Osiyemi is an employee of Triple O Research Institute. Kimberly Cruz is an employee of Advanced Pharma. Howard Hassman is an employee of CenExel HRI. Juan Carlos Rondon is an employee of Clinical Pharmacology of Miami, LLC.
: This study was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments. An institutional review board (Advarra IRB, Columbia, MD, USA) approved the protocol. Written informed consent was obtained from all participants.
